These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2939211)

  • 1. Serotonin and the blood vessel wall.
    Vanhoutte PM; Lüscher TF
    J Hypertens Suppl; 1986 Apr; 4(1):S29-35. PubMed ID: 2939211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and the blood-vessel wall.
    Vanhoutte PM
    J Hypertens Suppl; 1986 Dec; 4(5):S112-5. PubMed ID: 3553471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of serotonin.
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S8-11. PubMed ID: 2446079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of vasoconstrictor responses to serotonin by acute and chronic factors: inhibition by ketanserin.
    Van Nueten JM; Janssens WJ
    J Hypertens Suppl; 1986 Apr; 4(1):S55-9. PubMed ID: 2939213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between S2-serotonergic and alpha 1-adrenergic receptor activities at vascular sites.
    Van Nueten JM; Janssens WJ; Xhonneux R; Janssen PA
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S10-5. PubMed ID: 2459506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can peripheral serotonergic blockade explain the hypotensive effect of ketanserin?
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S105-9. PubMed ID: 2412025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.
    Van Nueten JM; Janssen PA; Van Beek J; Xhonneux R; Verbeuren TJ; Vanhoutte PM
    J Pharmacol Exp Ther; 1981 Jul; 218(1):217-30. PubMed ID: 6113280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium dysfunction in the coronary circulation.
    Lüscher TF; Noll G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S16-26. PubMed ID: 7700060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-hydroxytryptamine and vascular disease.
    Vanhoutte PM
    Fed Proc; 1983 Feb; 42(2):233-7. PubMed ID: 6822294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade.
    Cohen RA
    J Pharmacol Exp Ther; 1986 May; 237(2):548-52. PubMed ID: 2939235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT(2A) receptors.
    Shen FM; Wang J; Ni CR; Yu JG; Wang WZ; Su DF
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):702-7. PubMed ID: 17600544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin, hypertension and vascular disease.
    Vanhoutte PM
    Neth J Med; 1991 Feb; 38(1-2):35-42. PubMed ID: 2030808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age and the platelet serotonin vasoconstrictor axis in essential hypertension.
    Amstein R; Fetkovska N; Lüscher TF; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S35-40. PubMed ID: 2459512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive effects of serotonin on proximal coronary arteries in awake dogs.
    Chu A; Cobb FR
    Circ Res; 1987 Nov; 61(5 Pt 2):II81-7. PubMed ID: 3664987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.
    Leysen JE; Eens A; Gommeren W; van Gompel P; Wynants J; Janssen PA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):310-21. PubMed ID: 3336007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin and vascular reactivity.
    Van Nueten JM; Janssens WJ; Vanhoutte PM
    Pharmacol Res Commun; 1985 Jul; 17(7):585-608. PubMed ID: 2931729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of serotonin on platelets and blood vessels.
    De Clerck F
    J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S1-5. PubMed ID: 1717767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibition attenuates arterial constrictor responses in experimental hypertension.
    Kähönen M; Mäkynen H; Wu X; Arvola P; Pekki A; Pörsti I
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1701-9. PubMed ID: 8667241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular effects of serotonin and ischemia.
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S15-9. PubMed ID: 1369711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-hydroxytryptamine and precapillary vessels.
    Van Nueten JM
    Fed Proc; 1983 Feb; 42(2):223-7. PubMed ID: 6295823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.